Related Experiment Video
Updated: Aug 20, 2026

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
Published on: March 1, 2024
Vulnerability and presenting symptoms in burning mouth syndrome
Philip-John Lamey1, Ruth Freeman, Sally-Anne Eddie
1School of Dentistry, Queen's University, Belfast, Northern Ireland.
Objectives:
To investigate if burning mouth syndrome (BMS) patients have differing health perceptions, medication, and life experiences compared with controls and to examine the role of vulnerability factors and differentiate them from the presenting symptomology in patients with BMS.
Study Design:
A nonprobability convenience sample of patients presenting with BMS and age- and sex-matched controls were recruited from Queen's University, Belfast, King's College London, and Baylor College of Dentistry, Dallas. Participants completed a questionnaire to assess 9 aspects of their medical and social history, including early and past life experiences. The subjects completed the Hospital Anxiety and Depression Scale to assess current distress.
Results:
Participants with BMS had significantly higher experiences of adverse early life experiences compared with controls. They had statistically significantly higher mean scores for anxiety and depression compared with controls. A hierarchical multiple logistic regression analysis showed that the characteristics of BMS included cancer phobia, gastro-intestinal problems, and chronic fatigue.
Conclusion:
BMS is a complex disorder. People who experience adverse life experiences may become vulnerable to developing BMS in later life.
Related Concept Videos
Candidiasis
Assessment of the Mouth
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Herpes
Endocarditis II: Clinical Features of Infective Endocarditis
Peptic Ulcer Disease III: Clinical Manifestations and Complications

